Vitamin
A
Subj: Cod Liver Oil / Bethanecol
Date: 2/7/00
(This
is not intended to be a specific medical recommendation.
Any medical intervention should be carefully discussed with
your healthcare professional.)
As
with secretin, I listened to the story and rationale and then
did my own reality testing on some patients to see about Mary
Megson's Cod Liver Oil / Bethanecol idea. My early impression
is quite positive, and I think this needs to be passed along
to other clinicians who may want to look at this in parallel
to our work under the IRB. Bethanecol is an oral parasympathetic
agonist, very similar to endogenous acetylcholine, but more
resistant to inactivation by endogenous acetylcholinesterase
and therefore much longer acting. It has a good safety record,
at least in the adult, non-autistic population.
We
have a pretty good idea from Stephen Davies' work and by inference
that many of our kids are hypochlorhydric, and this must diminish
the secretion of pancreatic digestive enzymes and peptide
messengers like secretin with receptors outside the gut. Bethanecol
is a strong pancreatic stimulant. It has a ubiquitous positive
effect on gastric acid secretion. Happily, this increased
parietal cell acitivity isn't usually associated with increased
gastro-esophageal reflux. Rather, there is a very long clinical
tradition using Bethanecol expressly for symptoms of G.E.-reflux.
In
healthy adult males, Bethanecol increased gastric-residence
time by 64%, but did not affect mouth-to-cecum time. (Pharmacotherapy
9[4] 226-231, 1989). Increased volume of stomach acid and
increased time of exposure to it in the stomach would seem
beneficial to digestion and absorption. In spite of its parasympathetic
qualities, Bethanecol does not appear to cause problems with
hypermotility, and my very first Bethanecol patient had his
first-ever formed stool the following day. Improved digestion
and more ordered peristalsis may explain the firmed stool.
I
have observed truly marked language and social gains within
40 minutes of the first dose of Bethanecol, as if a switch
had been flipped. Bethanecol could have such an immediate
effect either as a strong pancreatic stimulant physiologically
upstream to Secretin or through its own effect at numerous
known CNS binding cites (Biochemical Pharmacology 38[5]: 837-50,
1989, Mar 1). My early impression, by the way, is that the
children who have demonstrated a response to secretin may
fall within the group of likely Bethanecol-responders.
I
am very happy to add to this discussion some recent literature
research from Teresa Binstock and Linda Carlton. Experimentally,
Bethanecol stimulates secretion of numerous antimicrobial
peptides (defensins) by the small intestine (Infect Immunol
64[12]:5161-5 Dec 1996. These defensins may have a wide spectrum,
including antiviral. One child with damaged intestinal ganglia
and pseodo-obstruction associated with active Epstein Barr
was treated successfully with Bethanecol. (Am J Gastroenterol
95[1]:280-4 Jan 2000) Dysbiosis control could be an important
mechanism.
The
official literature suggests contraindication in asthma, seizures,
hyperthyroidism and peptic ulcer, though one clinician reports
a definite pattern of improvement with Bethanecol in numerous
patients with seizure activity, and I have used it effectively
in one child with quiescent reactive airway disease. At the
low doses being used, no significant abdominal pain or other
clinical suggestion of ulcer activation is being seen. I strongly
advise observation of the first dose in the office for one
hour with injectable Atropine handy in the unlikely case of
respiratory difficulties.
The
thin, scored 10 mg Bethanecol tablets are easily halved or
quartered for starting doses of 2.5-5.0 mg. For the tablet-averse,
Bethanecol has been shown stable in water solution for at
least thirty days (Ann. of Pharmacotherapy 31 Mar p 294-6
1997). There may be a preference for the generic Bethanecol
over the proprietary ("Urecholine") in order to avoid the
dyes. It is inexpensive.
Some
adults have been on Bethanecol for many years for heartburn
or urinary retention, but we must advise parents that safety
in children over long periods has not been established. If
a significant part of its mechanism is improved digestion
and assimilation of nutrients, then perhaps the need for the
Bethanecol will lessen over time.